Scientific Letters
Vol. 9 No. 1 (2017): Review, Original Articles, Case Reports
https://doi.org/10.4084/mjhid.2017.047

How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: April 13, 2017
Accepted: July 16, 2017
Published: August 14, 2017
2576
Views
1512
Downloads
900
HTML
G6PD, Aspergillosis, Candida, Acute Myeloid Leukemia, Fungal Infection
Hematology

Authors

Marco Sanna
Department of Medical Sciences University of Cagliari Bone Marrow Transplant Centre Hospital "R. Binaghi", Cagliari, Italy, Italy.
Giovanni Caocci
giovanni.caocci@unica.it
Department of Medical Sciences University of Cagliari Bone Marrow Transplant Centre Hospital "R. Binaghi", Cagliari, Italy, Italy.
Giorgio La Nasa
Department of Medical Sciences University of Cagliari Bone Marrow Transplant Centre Hospital "R. Binaghi", Cagliari, Italy, Italy.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Luzzatto L, Nannelli C, Notaro R. Glucose-6-Phosphate Dehydrogenase Deficiency. Hematol Oncol Clin North Am. 2016; 30:373–93.
Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014; 164:469–480.
Spolarics Z, Siddiqi M, Siegel JH, et al. Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med. 2001; 29:728-36.
Abu-Osba YK, Mallouh AA, Hann RW. Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr. 1989; 114:748-52.
Meloni T, Forteleoni G, Ena F, et al. Glucose-6-phosphate dehydrogenase deficiency and bacterial infections in northern Sardinia. J Pediatr. 1991; 118:909-11.
Rodey GH, Jacob HS, Holmes B, et al. Leucocyte G6PD levels and bacterial activity. Lancet, 1970; 1:355-6.
Sanna M, Caocci G, Ledda A, et al. Glucose-6-Phosphate Deidhrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia. Leuk Lymphoma. 2017; Epub ahead of print
Domingo GJ, Satyagraha AW, Anvikar A, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Seidlein L.Malar J. 2013;12:391
Lamoth F, Cruciani M, Mengoli C, et al. Third European Conference on Infections in Leukemia (ECIL-3). β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis. 2012;54:633-43
Pappas GP. Clinical Infectious Diseases Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious DiseasesSociety of America.Clin Infect Dis. 2016;62:e1-50.
Tissot F, Agrawal S, Pagano L. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017; 102:433-444.

Ethics Approval

Scientific letter

How to Cite



“How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency” (2017) Mediterranean Journal of Hematology and Infectious Diseases, 9(1), p. e2017047. doi:10.4084/mjhid.2017.047.